South Africa's govt sets aside 900 million rand for antiretroviral programs

29 October 2009

The South African Treasury has made significant additions to the government's budget for HIV/ AIDS programs in anticipation of meeting its target of providing treatment to 80% of those in need by 2011, says the nation's Business Day.

Finance Minister Pravin Gordhan yesterday announced an extra 900 million ($120.6 million) for providing AIDS drugs in state health facilities for the rest of this fiscal year. The money will help meet the 1 billion rand shortfall acknowledged last month by Health Minister Aaron Motsoaledi.

Treatment is expected to exceed more than 300 000 new entrants a year. By the end of March next year, nearly 900 000 people will be receiving antiretroviral therapy, and about 80% of new HIV and AIDS cases will be entering treatment by 2011/2012.

The Department of Health has also introduced three new health vaccines and plans a mass vaccination campaign to reduce the incidence of measles.
A new occupation-specific salary dispensation for medical workers, introduced in 2007, is to be phased in over a three-year period. The salary scale will help the public sector attract and retain skilled professionals.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical